HU9800374D0 - Sulfonamide-substituted chromanes, process for producing them, their use as medicines or diagnostics, and pharmaceutical compositions containing them - Google Patents

Sulfonamide-substituted chromanes, process for producing them, their use as medicines or diagnostics, and pharmaceutical compositions containing them

Info

Publication number
HU9800374D0
HU9800374D0 HU9800374A HUP9800374A HU9800374D0 HU 9800374 D0 HU9800374 D0 HU 9800374D0 HU 9800374 A HU9800374 A HU 9800374A HU P9800374 A HUP9800374 A HU P9800374A HU 9800374 D0 HU9800374 D0 HU 9800374D0
Authority
HU
Hungary
Prior art keywords
sulfonamide
diagnostics
medicines
producing
pharmaceutical compositions
Prior art date
Application number
HU9800374A
Other languages
English (en)
Inventor
Joachim Brendel
Uwe Gerlach
Hans Jochen Lang
Klaus Weidmann
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of HU9800374D0 publication Critical patent/HU9800374D0/hu
Publication of HUP9800374A2 publication Critical patent/HUP9800374A2/hu
Publication of HUP9800374A3 publication Critical patent/HUP9800374A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
HU9800374A 1997-02-20 1998-02-20 Sulfonamide-substituted chromanes process for producing them, their use as medicines and pharmaceutical composition containing them HUP9800374A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19706675A DE19706675A1 (de) 1997-02-20 1997-02-20 Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (3)

Publication Number Publication Date
HU9800374D0 true HU9800374D0 (en) 1998-04-28
HUP9800374A2 HUP9800374A2 (en) 2000-07-28
HUP9800374A3 HUP9800374A3 (en) 2001-02-28

Family

ID=7820907

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9800374A HUP9800374A3 (en) 1997-02-20 1998-02-20 Sulfonamide-substituted chromanes process for producing them, their use as medicines and pharmaceutical composition containing them

Country Status (21)

Country Link
US (1) US6071953A (hu)
EP (1) EP0860440A1 (hu)
JP (1) JPH10231293A (hu)
KR (1) KR19980071530A (hu)
CN (1) CN1194982A (hu)
AR (1) AR011153A1 (hu)
AU (1) AU5539798A (hu)
BR (1) BR9800708A (hu)
CA (1) CA2229947A1 (hu)
CZ (1) CZ48598A3 (hu)
DE (1) DE19706675A1 (hu)
HR (1) HRP980086A2 (hu)
HU (1) HUP9800374A3 (hu)
IL (1) IL123360A0 (hu)
NO (1) NO980694L (hu)
NZ (1) NZ329788A (hu)
PL (1) PL324942A1 (hu)
SK (1) SK20998A3 (hu)
TR (1) TR199800253A2 (hu)
TW (1) TW474929B (hu)
ZA (1) ZA981376B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0895994A3 (de) 1997-08-05 1999-12-15 Hoechst Marion Roussel Deutschland GmbH Sulfonamid-substituierte Pyranopyridine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19742509A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19742508A1 (de) 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19748469A1 (de) * 1997-11-03 1999-05-06 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
JP2002524457A (ja) * 1998-09-04 2002-08-06 ザ プロクター アンド ギャンブル カンパニー 抗不整脈薬として有用な置換ジヒドロベンゾピラン
DE19858253A1 (de) 1998-12-17 2000-06-21 Aventis Pharma Gmbh Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
WO2000058300A1 (fr) * 1999-03-25 2000-10-05 Nissan Chemical Industries, Ltd. Derives du chroman
TW200403058A (en) * 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
US7368582B2 (en) 2003-10-17 2008-05-06 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them
EP2595623B1 (en) 2010-07-19 2018-02-28 The U.S.A. as represented by the Secretary, Department of Health and Human Services Use of delta tocopherol for the treatment of lysosomal storage disorders
WO2014078573A2 (en) 2012-11-16 2014-05-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Tocopherol and tocopheryl quinone derivatives as correctors of lysosomal storage disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006195A1 (fr) * 1987-02-13 1988-08-25 Centre De Recherches Metallurgiques-Centrum Voor R Installation pour la fabrication en continu d'une feuille metallique extra-mince par depot electrolytique
FR2639349B1 (fr) * 1988-11-23 1991-02-22 Sanofi Sa Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof
US5382587A (en) * 1993-06-30 1995-01-17 Merck & Co., Inc. Spirocycles
EP0807629B1 (de) * 1996-05-15 2004-03-03 Aventis Pharma Deutschland GmbH Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
BR9800708A (pt) 1999-07-20
HUP9800374A2 (en) 2000-07-28
HRP980086A2 (en) 1998-10-31
CA2229947A1 (en) 1998-08-20
NO980694D0 (no) 1998-02-19
AR011153A1 (es) 2000-08-02
NO980694L (no) 1998-08-21
HUP9800374A3 (en) 2001-02-28
TR199800253A2 (xx) 1998-09-21
CN1194982A (zh) 1998-10-07
DE19706675A1 (de) 1998-08-27
PL324942A1 (en) 1998-08-31
JPH10231293A (ja) 1998-09-02
EP0860440A1 (de) 1998-08-26
KR19980071530A (ko) 1998-10-26
ZA981376B (en) 1998-08-20
AU5539798A (en) 1998-08-27
IL123360A0 (en) 1998-09-24
SK20998A3 (en) 1998-10-07
US6071953A (en) 2000-06-06
NZ329788A (en) 1999-06-29
TW474929B (en) 2002-02-01
CZ48598A3 (cs) 1998-09-16

Similar Documents

Publication Publication Date Title
HU9700903D0 (en) Sulfonamide-substituted chromanes, process for producing them, their use as pharmaceutical compositions or diagnostica, and pharmaceutical compositions containing them
HUP9802300A3 (en) N-heteroaryl-pyridinesulfonamide derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP0001116A3 (en) Disubstituted bicyclic heterocycle, pharmaceutical compositions containing them and process for producing them
HUP9601529A3 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9802839A3 (en) Quinazoline derivatives, pharmaceutical compositions containing them and process for producing them
HUP9600071A3 (en) Indolo-piperidine derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9600876A3 (en) Benzonitril- and -fluoride derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9801423A3 (en) Chromene derivatives, process for producing them and pharmaceutical compositions containing them
HU9601358D0 (en) Fluoro-phenyl-substituted alkenyl-carboxylic-guanidines, process for producing them, their use as medicines or diagnostica, and pharmaceutical compositions containing them
HUP9600192A1 (en) Basic substituted benzoyl-guanidines, process for producing them, their use as medicines or diagnostics, and pharmaceutical compositions containing them
HU9800374D0 (en) Sulfonamide-substituted chromanes, process for producing them, their use as medicines or diagnostics, and pharmaceutical compositions containing them
HUP0003148A2 (en) Cyanoguanidine derivatives, process for producing them and pharmaceutical compositions containing them
HU9802155D0 (en) Sulfonamide-substituted chromanes, process for producing them, their use as medicine, and pharmaceutical compositions containing them
HUP0201785A3 (en) Dihydrobenzodiazepins, process for producing them, their use and pharmaceutical compositions containing them
HUP9601062A3 (en) Chromone derivatives, pharmaceutical compositions containing them and process for their preparation
HUP0003150A3 (en) Cyanoguanidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0104002A3 (en) Alpha2-antagonists tricyclic delta3-piperidines, process for their producing the pharmaceutical compositions containing them and their use as medicament
HU9802518D0 (en) Sulfonamide-substituted benzopirane derivatives, process for producing them, their use as pharmaceuticals and pharmaceutical compositions containing them
HU9802156D0 (en) Sulfonamide-substituted chromanes, process for producing them, their use as medicine, and pharmaceutical compositions containing them
HUP0003829A2 (en) Cyanoguanidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0003766A3 (en) Isoguinolin derivatives, process for producing them and pharmaceutical compositions containing them
HUT73975A (en) Substituted benzol-sulfonyl-ureas and-thioureas, process for producing them, pharmaceutical compositions containing them and their use
HU9801789D0 (en) Sulfonamide-substituted compounds, process for producing them, their use as pharmaceutical compositions and diagnostics, and pharmaceutical compositions containing said compounds
HUP9800395A3 (en) Sulfonamide-substituted benzoxepine derivatives, their use as medicines and pharmaceutical compositions containing them
HUP0003997A3 (en) 3-benzylpiperidine derivatives, pharmaceutical compositions containing them and process for producing them